Annual Drug Patent Expirations for DELSTRIGO
Delstrigo is a drug marketed by Msd Merck Co and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has sixty-nine patent family members in forty-three countries.
The generic ingredient in DELSTRIGO is doravirine; lamivudine; tenofovir disoproxil fumarate. One supplier is listed for this compound. Additional details are available on the doravirine; lamivudine; tenofovir disoproxil fumarate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
